IN A COLLABORATION WITH MAHAK, ACTERO MEMBERS TOOK PART IN A STEM CELL DONATION PROGRAM

September 1, 2018

Author: Acteropharma

Members of Actero family took part in a stem cell donation program by giving a sample of their salvia. The program was executed on 14th August at the company head office by Mahak charity and samples were gathered for submission to Human Leukocyte Antigen bank. “As a company active in manufacturing oncology products we are well aware of the hardship of cancer treatment; that is why we feel responsible to partake in such programs.” CEO of Actero Actero is a pharmaceutical company specialized in high-quality oncology products and has over 15 products under development or pending Ministry of Health approval. Mahak, the society to support children from cancer, has provided comprehensive coverage and treatment to over 27000 children and their families.

Last News

Actero Support in Congress 1400

Site
July 24, 2022

Author:

Acteropharma
Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

Dr-noroozi-event-2048x1367
November 16, 2021

Author:

Acteropharma
The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

Dr-noroozi-event-2048x1367
November 16, 2021

Author:

Acteropharma
Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.